New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Probiotic LRC for heart health benefits [white paper]

Paid content

Cardiovascular disease is considered the principal global cause of morbidity and mortality by the World Health Organization. In the United States, one in three deaths occurs as a result of CVD; half of these due to coronary artery disease (CAD). Estimated costs associated with CVD and stroke in the U.S. reached nearly $300 billion in 2008 and are projected to triple by 2030.

A number of modifiable risk factors have been identified; adopting healthy and therapeutic lifestyle habits is an important part of managing cardiovascular risk and reducing costs associated with the disease.

Probiotics have gained great interest among consumers of health products, physicians, and scientists, and a remarkable research focus is examining the role of these micro-organisms on metabolic functions.

Download this free white paper to learn more.